NEWS
‹ Back all news
2010 - 06 - 04 COMPLIX Luxembourg
Complix NV, a recently founded biopharmaceutical company, announced on June 4, 2010 the successful closing of its Series A financing round, raising €5 million (~US$6.25 million) from a syndicate of leading life sciences investors. The transaction was co-led by Vesalius Biocapital (Luxembourg) and LRM (Belgium), with CRP-Santé (Luxembourg), existing investors and management also participating.
For detailed information and press releases, please refer to this page .